Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 20, 2020
- Accepted for publication February 3, 2021
- Published online November 1, 2021.
Article Versions
- previous version (March 12, 2021 - 11:03).
- previous version (March 26, 2021 - 13:39).
- previous version (May 14, 2021 - 18:26).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2021 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
Author Information
- Quentin Lecocq1,
- Robin Maximilian Awad1,
- Yannick De Vlaeminck1,
- Wout de Mey1,
- Thomas Ertveldt1,
- Cleo Goyvaerts1,
- Geert Raes2,3,
- Kris Thielemans1,
- Marleen Keyaerts4,5,
- Nick Devoogdt*,4 and
- Karine Breckpot*,1
- 1Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium;
- 2Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium;
- 3Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium;
- 4In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium; and
- 5Nuclear Medicine Department, UZ Brussel, Brussels, Belgium
- For correspondence or reprints, contact Nick Devoogdt (nick.devoogdt{at}vub.be) or Karine Breckpot (karine.breckpot{at}vub.be).
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside
- Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma
- Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes
- Implication of 99mTc-sum IL-2 SPECT/CT in immunotherapy by imaging of tumor-infiltrating T cells
- Single-Domain Antibody Theranostics on the Horizon
- MRI techniques for immunotherapy monitoring